Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium voltage-gated channel subfamily D member 1 (KCND1) is a pore-forming alpha subunit of the A-type voltage-gated potassium channel family (Kv4.1). It is a multipass membrane protein essential for mediating the fast, transient outward potassium current (I_A) in excitable cells, notably within the brain and heart. KCND1 plays a key role in the repolarization phase of action potentials, thereby contributing to the regulation of neuronal firing patterns, circadian rhythms, cardiac conduction, hormone secretion (such as insulin), and smooth muscle contraction. Dysregulation or genetic variants of KCND1 are associated with diseases including epilepsy and Long QT syndrome, and research suggests a possible role in cancer cell proliferation. The channel's activity is modulated by regulatory subunits and biochemical factors, but it remains primarily a research target rather than a current therapeutic target in clinical practice[1][2][4][6].
Drugs that inhibit A-type voltage-gated potassium channels reduce the A-type potassium current (I_A), affecting neuronal excitability, action potential repolarization, and possibly circadian patterns[4][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily D member 1 (KCND1).